USSTOCK.TODAY
Market Closed
Log in Sign up

Autolus Therapeutics reports 95% Q3 revenue growth and raises guidance

The Motley Fool +1 · ·by G4L

AUTL
AUTL Autolus Therapeutics plc ADR
$1.32 0.00%
View chart & analysis →
  1. 1Autolus Therapeutics recorded a 95% year-over-year revenue growth rate in the third quarter.
  2. 2Autolus Therapeutics announced an upward revision of its full-year 2026 revenue guidance to over $150 million.
  3. 3Autolus Therapeutics achieved a gross margin of 57% in the recent period.

So what's the key point?

Autolus Therapeutics saw its revenue grow by 95% compared to the same period last year in the third quarter.

Source The Motley Fool +1 · View original ↗

Related 3-line summaries

Gilat Satellite shifts toward defense-centric revenue and pursues Comtech acquisition The Motley Fool +1 · 11m agoCoreWeave Q3 revenue surges 168%, but records $709 million net loss The Motley Fool +1 · 11m agoeToro Q3 Earnings Release: Fund Accounts and Assets Under Management Hit Record Highs The Motley Fool +1 · 16m ago
Today's 5 AI picks, all free
Nothing hidden: past picks and how they did against the S&P 500.
See today's picks →
← Back to news